ATE494367T1 - Rekombinante desoxyribonuclease i aus rinder- pankreas mit hoher spezifischer aktivität - Google Patents

Rekombinante desoxyribonuclease i aus rinder- pankreas mit hoher spezifischer aktivität

Info

Publication number
ATE494367T1
ATE494367T1 AT03028841T AT03028841T ATE494367T1 AT E494367 T1 ATE494367 T1 AT E494367T1 AT 03028841 T AT03028841 T AT 03028841T AT 03028841 T AT03028841 T AT 03028841T AT E494367 T1 ATE494367 T1 AT E494367T1
Authority
AT
Austria
Prior art keywords
desoxyribonuclease
recombinant
specific activity
high specific
bovine
Prior art date
Application number
AT03028841T
Other languages
English (en)
Inventor
Rainer Mueller
Bernhard Suppmann
Johann-Peter Thalhofer
Stephanie Ronning
Helmut Schoen
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE494367T1 publication Critical patent/ATE494367T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/16Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22Ribonucleases RNAses, DNAses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT03028841T 2002-12-18 2003-12-16 Rekombinante desoxyribonuclease i aus rinder- pankreas mit hoher spezifischer aktivität ATE494367T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02028115 2002-12-18
US43933503P 2003-01-10 2003-01-10
EP03001213 2003-01-20

Publications (1)

Publication Number Publication Date
ATE494367T1 true ATE494367T1 (de) 2011-01-15

Family

ID=43426137

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03028841T ATE494367T1 (de) 2002-12-18 2003-12-16 Rekombinante desoxyribonuclease i aus rinder- pankreas mit hoher spezifischer aktivität

Country Status (3)

Country Link
US (1) US7118901B2 (de)
AT (1) ATE494367T1 (de)
DE (1) DE60335602D1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090298095A1 (en) * 2005-04-15 2009-12-03 The John Hopkins University Immortalization of cells including neuronal cells
EP2086642B1 (de) 2006-10-18 2014-06-25 Periness Ltd. Dnase zur behandlung von subfertilität beim mann
LT2490986T (lt) 2009-10-21 2018-11-26 Revance Therapeutics, Inc. Nekompleksinio botulino neurotoksino gryninimo būdai ir sistemos
CA2791158C (en) 2010-02-26 2020-07-21 Decell Technologies Inc. Methods for tissue decellularization
TW201307563A (zh) * 2011-05-19 2013-02-16 Shire Human Genetic Therapies 純化乙醯肝素-n-硫酸酯酶之方法
CA2925332C (en) 2013-11-04 2022-07-12 Lifecell Corporation Methods of removing alpha-galactose
EP4247959A4 (de) * 2020-11-17 2024-10-09 Ginkgo Bioworks Inc Synthetische methanolinduzierbare promotoren und verwendungen davon

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ199722A (en) 1981-02-25 1985-12-13 Genentech Inc Dna transfer vector for expression of exogenous polypeptide in yeast;transformed yeast strain
EP0116201B1 (de) 1983-01-12 1992-04-22 Chiron Corporation Sekretorische Expression in Eukaryoten
US4870008A (en) 1983-08-12 1989-09-26 Chiron Corporation Secretory expression in eukaryotes
US4808537A (en) 1984-10-30 1989-02-28 Phillips Petroleum Company Methanol inducible genes obtained from pichia and methods of use
US4855231A (en) 1984-10-30 1989-08-08 Phillips Petroleum Company Regulatory region for heterologous gene expression in yeast
US4837148A (en) 1984-10-30 1989-06-06 Phillips Petroleum Company Autonomous replication sequences for yeast strains of the genus pichia
US4885242A (en) 1984-10-30 1989-12-05 Phillips Petroleum Company Genes from pichia histidine pathway and uses thereof
US4879231A (en) 1984-10-30 1989-11-07 Phillips Petroleum Company Transformation of yeasts of the genus pichia
US5032516A (en) 1985-10-25 1991-07-16 Phillips Petroleum Company Pichia pastoris alcohol oxidase II regulatory region
US4882279A (en) 1985-10-25 1989-11-21 Phillips Petroleum Company Site selective genomic modification of yeast of the genus pichia
US4818700A (en) 1985-10-25 1989-04-04 Phillips Petroleum Company Pichia pastoris argininosuccinate lyase gene and uses thereof
US5135868A (en) 1985-10-25 1992-08-04 Phillips Petroleum Company Cultures of yeast of the genus Pichia altered by site selective genomic modification
US5166329A (en) 1985-10-25 1992-11-24 Phillips Petroleum Company DNA encoding the alcohol oxidase 2 gene of yeast of the genus Pichia
US4895800A (en) 1985-11-26 1990-01-23 Phillips Petroleum Company Yeast production of hepatitis B surface antigen
US4812405A (en) 1986-02-18 1989-03-14 Phillips Petroleum Company Double auxotrophic mutants of Pichia pastoris and methods for preparation
US4857467A (en) 1986-07-23 1989-08-15 Phillips Petroleum Company Carbon and energy source markers for transformation of strains of the genes Pichia
US5002876A (en) 1986-09-22 1991-03-26 Phillips Petroleum Company Yeast production of human tumor necrosis factor
US4683293A (en) 1986-10-20 1987-07-28 Phillips Petroleum Company Purification of pichia produced lipophilic proteins
US5010182A (en) 1987-07-28 1991-04-23 Chiron Corporation DNA constructs containing a Kluyveromyces alpha factor leader sequence for directing secretion of heterologous polypeptides
US4929555A (en) 1987-10-19 1990-05-29 Phillips Petroleum Company Pichia transformation
US5004688A (en) 1988-04-15 1991-04-02 Phillips Petroleum Company Purification of hepatitis proteins
WO1990007572A1 (en) 1988-12-23 1990-07-12 Genentech, Inc. HUMAN DNase
US5122465A (en) 1989-06-12 1992-06-16 Phillips Petroleum Company Strains of pichia pastoris created by interlocus recombination
JPH06500470A (ja) 1990-09-04 1994-01-20 メルク エンド カンパニー インコーポレーテッド メチロトローフ酵母細胞におけるインスリン様成長因子の産生
CA2058820C (en) 1991-04-25 2003-07-15 Kotikanyad Sreekrishna Expression cassettes and vectors for the secretion of human serum albumin in pichia pastoris cells
CZ288633B6 (cs) 1995-02-24 2001-08-15 Genentech, Inc. Na aktin rezistentní varianta lidské DNázy I a izolovaná nukleová kyselina ji kódující
AU3910000A (en) 1999-03-22 2000-10-09 Zymogenetics Inc. Improved methods for producing proteins in transformed (pichia)
DE60035851D1 (de) 1999-08-17 2007-09-20 Tanuma Deoxyribonuklease, dafür kodierendes gen und verfahren

Also Published As

Publication number Publication date
US7118901B2 (en) 2006-10-10
US20040259197A1 (en) 2004-12-23
DE60335602D1 (de) 2011-02-17

Similar Documents

Publication Publication Date Title
ATE323510T1 (de) Gentherapeutische verfahren zur bereitstellung von apolipoprotein a-i agonisten sowie deren verwendung zur behandlung dyslipidämischer erkrankungen
DE69333112D1 (de) Modifizierte pilzzellen und methode zur herstelllung rekombinanter produkte
GB2438760A (en) Methods for expression and purification of recombinant human growth hormone
ATE213020T1 (de) Klonierung und expression von biologisch aktiver alpha-galaktosidase a
ATE397385T1 (de) Biofungizide
FI965031A0 (fi) Sieni, jossa AreA-geeni on muunnettu, ja Aspergillus oryzaesta peräisin oleva areA-geeni
ATE494367T1 (de) Rekombinante desoxyribonuclease i aus rinder- pankreas mit hoher spezifischer aktivität
ATE309353T1 (de) Verfahren zur herstellung von rekombinanten peptiden
DE60225312D1 (de) Samenspezifische 7s-alpha-promoter zur expression von genen in pflanzen
HUP0202596A2 (hu) Szignálszekvenciák Leu-hirudin előállítására E. coli általi szekréció révén tenyésztő tápközegben
DE602004025838D1 (de) Neuer brevibacillus choshinensis sowie verfahren zur herstellung von protein unter verwendung der mikrobe als wirt
EP1870454A4 (de) Verfahren zur dipeptidherstellung
ATE373097T1 (de) Modifizierte methylotrophe p. pastoris hefe, welche menschliches wachstumshormon sekretiert
DK0672150T3 (da) Modificeret Kluyveromyces-gær, fremstilling og anvendelse
DE60328813D1 (de) Mutanten für die herstellung von d-aminosäuren
EP1245681A3 (de) Verfahren zur Herstellung von pharmazeutisch aktiven, rekombinanten Proteinen umfassend die Verwendung von Alkansäuren, deren Derivate oder Salze
ATE445702T1 (de) Butinol i esterase
DE60318882D1 (de) Uroplakin-ii-promotor aus schwein und verfahren zur herstellung nützlicher proteine unter verwendung des promotors
DE60335703D1 (de) Verbesserte proteinexpression in bacillus subtilis
DE69737007D1 (de) Protein-disulfidisomerase-Gen eines methylotrophen Hefestammes
DE69634853D1 (de) Ftsy-exprimierende gram-positive mikroorganismen mit verbesserten sekretionseigenschaften
EP0190686A3 (de) Verfahren zur Herstellung von Gamma-Interferon
ATE482274T1 (de) Polypeptid mit amidaseaktivität und dessen gen
ATE356872T1 (de) Verwendung von protein maba (fabg1) aus mycobacterium tuberculosis zur herstellung und nachweis von antibiotika
ATE250126T1 (de) Methode zur herstellung rekombinanter proteine und dafür verwendete wirtszellen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties